OTC·Biological Products, (No Diagnostic Substances)
ABPO
Abpro Holdings, Inc.
Abpro Holdings, Inc. (ticker: ABPO) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of ABPO's SEC filings surfaces 12 active risk signals, including 10 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. ABPO reported $183K in revenue and -$3.89M for the period ending 2024-12-31, with operating cash flow of -$6.01M. Cash and equivalents stood at $67K (down 97.6% year-over-year). Total assets of $1.06M are exceeded by total liabilities of $19.61M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ABPO SEC Filings
Full cached SEC EDGAR filing history for ABPO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.